Published in Medical Letter on the CDC and FDA, January 29th, 2006
The new drug application (NDA) for Vivitrol, formerly known as Vivitrex, was submitted on March 31, 2005. Alkermes and Cephalon continue to prepare for the launch of Vivitrol during the second quarter of 2006.
FDA approval of Vivitrol is contingent upon finalizing the product label and satisfying a request by the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.